Sana revolutionizes treatments for diabetes, cancer, and autoimmune diseases. SANA has high cash burn and dilution risks. See ...

Johor is set to become Asia's largest insulin hub as India's leading biotechnology firm, Biocon Ltd, invests another RM1.1 ...

A study in the journal Diabetes Technology & Therapeutics (DTT) concludes that inhaled technosphere insulin (TI-Afrezza) ...

Russian drug manufacturers are eliminating global players from the domestic insulin market, as their sales are steadily ...

Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bw8539 ...

Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bw8539 ...

Cirius Therapeutics, Inc., developing innovative therapies for patients suffering with diseases caused by insulin resistance, ...

Type 2 diabetes is a chronic condition affecting millions worldwide that often requires insulin therapy when blood sugar ...

Global CEO of Eli Lilly, world’s pioneer Insulin manufacturers, David Ricks called on Union Minister of State (Independent ...

Exposure to antibiotics during a key developmental window in infancy can stunt growth of insulin-producing cells in the pancreas and may boost risk of diabetes later in life, new research in mice ...